Strobeck Mark
- SEC CIK
- 0001599219
In the past year, 1 open-market sale filing worth $8.24K and no purchases.
Current role at each company
- RMTI Rockwell Medical, Inc.President and CEOas of Jul 6, 2026
- WINT Windtree Therapeutics IncDirectoras of Aug 25, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $8.24K
- 1 filing
- Net
- −$8.24K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Strobeck Mark as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
RMTI Rockwell Medical, Inc.
President and CEO5 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Oct 1, 2025 (view filing) | Oct 1 | Same day | Strobeck MarkPresident and CEO | SSale | −6.93K | $1.19 | −$8.24K | −2.1%330.8K after | 10b5-1 |
| Jul 3, 2025 (view filing) | Jul 1 | 2 days | Strobeck MarkPresident and CEO | SSale | −6.93K | $0.82 | −$5.68K | −2.0%337.8K after | Amended10b5-1 |
| Apr 2, 2025 (view filing) | Apr 1 | 1 day | Strobeck MarkPresident and CEO | SSale | −6.93K | $1.08 | −$7.48K | −5.3%124.7K after | 10b5-1 |
| Jan 6, 2025 (view filing) | Jan 2 | 4 days | Strobeck MarkPresident and CEO | SSale | −2.16K | $2.06 | −$4.46K | −1.5%145.0K after | 10b5-1 |
| Oct 2, 2024 (view filing) | Oct 1 | 1 day | Strobeck MarkPresident and CEO | SSale | −2.16K | $3.69 | −$7.98K | −1.4%147.2K after | 10b5-1 |